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Purpose: Constrictive remodeling and new artery wall mass contribute to lumen narrowing in atherosclerosis and
following injury. Rho-kinase, an important regulator of myosin phosphorylation and cytoskeletal reorganization, is
critical to smooth muscle cell (SMC) growth and vasoconstriction, but its role in artery wall remodeling is poorly defined.
We hypothesized that constrictive artery wall remodeling is dependent on Rho signaling so that blocking Rho-kinase
would promote outward artery wall remodeling in response to intimal hyperplasia and thus limit lumen narrowing.
Methods: To test this hypothesis, we first studied the effects of the Rho-kinase inhibitor fasudil on SMC remodeling of
collagen matrix in vitro. Mouse aortic SMCs were seeded into three-dimensional collagen gels with and without fasudil,
and extent of contraction was measured at 24 hours. We then used the mouse carotid ligation model to study the effects
of Rho-kinase inhibition on remodeling and intimal hyperplasia in vivo. C57B6/J mice were randomly assigned to fasudil
(100 mg/kg per day) or vehicle and underwent unilateral carotid artery ligation or sham ligation. Remodeling and wall
mass were measured after 28 days.
Results: Fasudil blocked SMC contraction of collagen gels in a dose-dependent manner. Complete inhibition of collagen
gel remodeling was achieved between 10 and 30 mol/L fasudil. In control mice, carotid ligation caused significant
thickening of the adventitia, media, and intima (P < .01) and outward remodeling of the carotid wall. The external elastic
lamina (EEL) area increased by 14% versus sham (P < .05), but this increase was insufficient to prevent lumen narrowing
(42% vs sham, P < .05). Fasudil treatment had favorable effects on wall mass, inhibiting neointimal (P  .04), medial
(P  .03), and adventitial thickening (P  .07) versus controls. Opposite our hypothesis, however, fasudil did not
enhance outward artery wall remodeling or improve lumen caliber. Rather, inhibiting Rho-kinase blocked outward
remodeling in response to ligation. EEL area was significantly smaller in treated versus control animals (P  .04) and
slightly smaller versus shams (P  NS). These data suggest that Rho activation contributes significantly to both
hyperplasia and outward remodeling of the injured artery wall. Rho-kinase may prove an important target to limit intimal
hyperplasia and prevent restenosis when remodeling is improved by other means (eg, stents). (J Vasc Surg 2004;39:
223-8.)
Intimal hyperplasia and constrictive artery wall remod-
eling are the major structural events leading to lumen
narrowing in atherosclerosis and restenosis. Changes in
wall mass and geometry both require smooth muscle cell
(SMC) growth, migration, and extracellular matrix turn-
over, which, in turn, require complex cytoskeletal reorga-
nization. Activation of Rho-kinase by the small guanosine
triphosphatase (GTPase) Rho sets into motion a number of
intracellular signaling events such as myosin light chain
phosphorylation that contributes directly to actin cytoskel-
eton reorganization, cell contraction, and migration.1,2
Blocking Rho-kinase has been shown to reverse pathologic
vasospasm, block intimal hyperplasia after injury, and in-
hibit SMC replication and migration in vitro.1,3-9 How-
ever, the contribution of Rho signaling to pathologic con-
strictive artery wall remodeling remains poorly defined.
Outward remodeling of the artery wall is a key compen-
satory mechanism critical to maintaining arterial lumen
caliber as atherosclerotic plaque enlarges.10 A similar mech-
anism is believed to compensate for neointima accumulat-
ing within arteries injured during angioplasty and other
forms of reconstruction.11,12 Molecular regulation of re-
modeling is poorly understood, but changes in wall geom-
etry are likely influenced by vasomotor tone and constric-
tive matrix reorganization within the artery wall. We
hypothesized that inhibiting Rho-kinase would limit vaso-
constriction and constrictive matrix reorganization within
the injured artery wall, thereby promoting outward or
“compensatory” remodeling to enhance lumen caliber.
In support of our hypothesis, the Rho-kinase inhibitor
fasudil blocked collagen gel contraction by murine aortic
SMCs in vitro, and, consistent with previous reports,1,8
fasudil also inhibited intimal hyperplasia in mice following
carotid ligation. Despite favorable effects on artery wall
mass, outward remodeling of the artery wall was blocked by
fasudil so that lumen caliber was not improved. The remod-
eling effect was specific to injury, as outward artery remod-
eling in response to increased blood flow progressed nor-
mally despite Rho-kinase inhibition. These data suggest
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Rho-signaling is critical for outward remodeling and hyper-
plasia following arterial injury.
MATERIAL AND METHODS
Collagen remodeling in vitro. SMCs were cultured
from aortas of C57B6/J (Jackson Laboratories, Bar Har-
bor, Me) mice with the use of the explant method and
Dulbecco modified Eagle medium and Ham F12 nutrient
mixture (DMEM/F12) with 10% serum. Early passage
cells were trypsinized, washed, and resuspended in medium
(1.5  105 cells/mL) and then pretreated for 30 minutes
with 0.0, 0.1, 1.0, 5.0, 10.0, or 30.0 mol/L fasudil at
37°C, 5% CO2. Cells were then combined with type-I
collagen in solution (Vitrogen 100, 2 mg/mL) and poly-
merized at 37°C in 24-well plates as previously described.13
Polymerized gels were then covered with medium contain-
ing 0.0, 0.1, 1.0, 5.0, 10.0, or 30.0 mol/L fasudil,
respectively, and incubated at 37°C, 5% CO2. Gel remod-
eling was monitored by measuring gel diameter (millime-
ter) after 4, 8, 18, 21, and 24 hours, and all assays were run
in triplicate.
Animal model. Fifty male C57B6/J mice (age, 10
weeks, mean weight, 25 g; Jackson Laboratories) were
randomly assigned to treatment or control groups and then
acclimated to group housing in a pathogen-free barrier
facility. Mice were fed standard chow (Purina Pro Lab
R-M-H 3000; St Louis, Mo) and provided water ad lib.
The treatment group received the specific Rho-kinase in-
hibitor fasudil (100 mg/kg per day; Berlex Biosciences,
Richmond, Calif) in drinking water, and 2 days later all
animals underwent unilateral carotid ligation to induce
remodeling and intimal hyperplasia as previously de-
scribed.14,15 Anesthesia was induced with a brief exposure
to inhaled halothane, followed by intraperitoneal ketamine
(110 mg/kg) and xylazine (6.4 mg/kg). Using aseptic
technique, we exposed the left common carotid artery
through a ventral neck incision and ligated its bifurcation
with 6-0 polypropylene suture (Ethicon, Somerville, NJ).
Separate mice underwent carotid artery exposure without
ligation (sham, N 8 animals). Neck incisions were closed
with absorbable suture, and animals recovered in a warming
box prior to returning to group housing. Animal care and
procedures were approved by the Wake Forest University
Animal Care and Use Committee and conformed to stan-
dards set forth by the National Institutes of Health.16
Drug administration. Water consumption for each
cage was measured at baseline and was used to calculate
drug concentration (0.6 mg/mL) needed to deliver 100
mg/kg per day fasudil. Distilled water with or without
fasudil was then filter-sterilized and used to fill water bottles
for treatment and control mice, respectively. Water con-
sumption was monitored daily, and treatment was begun 2
days prior to surgery, then continued for 28 days after
surgery.
Histology and morphometry. Animals were anesthe-
tized on day 28 (as described earlier), and the left ventricle
was cannulated with a 25-gauge needle. The vasculature
was rinsed free of blood with Ringer solution, followed by
10% buffered formalin at physiological pressure. The heart,
aorta, and carotid arteries were removed en bloc with
adjacent tissues, immersed in formalin for 36 hours, and
then transferred to 70% ethanol. Fixed carotid arteries were
left attached to the innominate artery and aorta to maintain
orientation and were dissected free of surrounding struc-
tures under magnification. Arteries were then embedded in
paraffin perpendicular to the axis of sectioning. This tech-
nique allowed for cutting of cross-sections of right and left
carotids on the same slide for analysis from the same loca-
tion relative to the bifurcation. Serial sections (5 m thick)
were cut at 50-m intervals from distal to proximal, starting
800 m proximal to the left carotid ligature. In sham
animals, sectioning began 1 mm proximal to the carotid
bifurcation. Slides were stained with Verhoeff van Gieson
stain and projected onto a calibrated digitizing pad for
computer-assisted morphometric analysis by a blinded ob-
server as previously described.11,12
For both ligated and nonligated carotid arteries the
perimeter length and area encompassed by the peripheral
margin of the vessel adventitia, the external elastic lamina
(EEL), internal elastic lamina (IEL), and lumen were mea-
sured. Adventitial, medial, and intimal areas were then
calculated by subtraction. Lumen caliber and artery wall
size (lumen area and area encompassed by the EEL, respec-
tively) were calculated from perimeter lengths, assuming a
circular structure to control for asymmetry of the vessel wall
introduced by processing and embedding.
Changes in wall mass were estimated from the cross-
sectional areas of each vessel layer (adventitia, media, and
intima) individually and collectively. Remodeling was de-
termined by measuring changes in artery wall size defined
as the area encompassed by the EEL. To gain insight into
the mechanism underlying changes in wall mass (eg,
change in cell number vs altered ratio of cells to extracellu-
lar matrix), cell density was determined for each layer of the
ligated artery wall in treated and control animals. Sections
adjacent to those used for morphometry were stained with
hematoxylin and eosin, and cell nuclei were counted in each
vessel wall compartment at 400 magnification. Density
was then calculated as nuclei by cross-sectional area in each
wall layer (cells/mm2).
Statistical analysis. Data for each end point were
derived from three separate cross-sections from each ca-
rotid artery. Values were averaged to derive the mean of
means  SEM for end points within each group. Differ-
ences between groups were modeled by using the unpaired,
two-tailed Student t test, and comparisons within individ-
ual animals by using the paired, two-tailed Student t test
with significance assigned at P .05.
RESULTS
Collagen matrix remodeling in vitro. Three-dimen-
sional collagen matrices are commonly used to model
wound healing and contractile matrix reorganization in
vitro. Murine aortic SMCs significantly contracted collagen
gels, reducing gel diameter by 40% at 24 hours (Fig 1).
Blocking Rho-kinase resulted in a dose-dependent reduc-
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tion of collagen gel remodeling with complete inhibition of
gel contraction at 24 hours by SMCs pretreated with 30
mol/L fasudil and a 62% decrease in gel contraction by
SMCs pretreated with 10 mol/L fasudil (P .01, Fig 1).
Similar inhibition was observed in collagen gel contraction
by primate aortic SMCs pretreated with fasudil (Geary RL,
unpublished observations, 2002).
Artery wall remodeling in vivo. Two mice from each
group died at surgery, leaving 46 mice to complete the
28-day protocol. Of these mice, 19 were in treatment and
19 in control groups undergoing ligation. Another 8 ani-
mals (4 treated and 4 controls) underwent sham ligation,
providing 8 sham carotid arteries per group for analysis.
Animals in all groups remained healthy and gained an
appropriate amount of weight during the protocol, which
did not differ significantly between groups. Water con-
sumption was carefully monitored and was similar for
treated and control animals (4.04  0.18 vs 3.84  0.16
mL/day, P  NS). Treated animals received 99.5  2.1
mg/kg per day fasudil (range, 67.5-115.6 mg/kg per day)
on the basis of preoperative weight.
Inhibition of Rho-kinase and normal carotid artery
structure. Normal mouse carotid arteries (Fig 2) consist
of an endothelial cell monolayer (intima), two to three
elastic lamellae containing SMCs (media), and a thin outer
connective tissue layer (adventitia). All sham-ligated ca-
rotids were normal in appearance, patent, and available for
morphometric analysis at the end of the protocol. Fasudil
had no effect on artery wall mass or remodeling in these
normal arteries. All arteries were free of neointima, and the
cross-sectional medial and adventitial areas were the same
in treated and untreated shams (PNS). Moreover, fasudil
did not cause dilation or outward remodeling, as artery wall
size (EEL area) and lumen area were unchanged by treat-
ment (P  NS).
Ligation induces artery wall hyperplasia. At nec-
ropsy, 6 ligated arteries in each group had sectioning arti-
fact or thrombosis that precluded analysis according to the
protocol. These vessels were excluded from analysis. In the
remaining control mice (N 13) ligation led to hyperplasia
of each artery wall layer at 28 days (Fig 2). Cross-sectional
area of the adventitia, media, and neointima was signifi-
cantly larger than in shams or the contralateral nonligated
carotid artery (Table I). Outward wall remodeling was
noted in both the ligated and contralateral nonligated
carotids (P  .05) of control animals with corresponding
increases in the area within the EEL versus shams (Table I; Fig
3). In the nonligated artery this response was likely compen-
Fig 1. Chart demonstrating collagen gel contraction by murine aortic SMCs and inhibition of collagen contraction by
fasudil.
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satory to increased blood flow and shear stress. In the ligated
artery, despite cessation of net forward flow, the wall also
remodeled outward in response to intimal hyperplasia. How-
ever, the increase in wall caliber was insufficient to accommo-
date new intimal and medial thickening, so the lumen was
narrowed significantly (P .05 vs sham; Table I; Fig 3).
Rho-kinase inhibition limited hyperplasia and
blocked outward remodeling. Fasudil reduced the ex-
tent of hyperplasia following carotid ligation. Neointimal
and medial areas were each reduced 65% and 22%, respec-
tively, compared with controls (P  .05). Additionally,
adventitial area was reduced 37% compared with controls
(P  .07; Table I; Fig 4). The effect on wall mass was due
to reduction in total cell accumulation and not to altered
extracellular matrix production, as the density of cells in the
neointima, media, and adventitia was not different than in
controls (Table II; P  NS). This finding suggests that
fasudil inhibited replication and/or enhanced apoptosis,
consistent with previous reports.5,8,17
Conversely, fasudil did not enhance outward artery wall
remodeling. In fact, treatment blocked the outward re-
modeling noted in ligated arteries of control mice. The area
within the EEL of ligated arteries in treatment animals was
significantly reduced relative to controls (P  .04; Table I;
Fig 4). Although not statistically significant, artery size was
smaller in treated animals than in shams, suggesting wall
shrinkage or constrictive remodeling had occurred. Thus,
despite reducing hyperplasia, treatment did not improve
lumen caliber because of the relatively greater effect on
geometric remodeling (lumen area P  NS, treated vs
control). The carotid artery opposite the side of ligation
demonstrated outward wall remodeling in response to in-
creased blood flow and shear stress (Table I). In contrast to
the effect on remodeling in response to ligation, fasudil did
not inhibit flow-induced remodeling, as the area within the
EEL of nonligated arteries was similar in treated and con-
trol mice (P  .53; Table I).
DISCUSSION
Consistent with previous reports, carotid artery ligation
caused a significant increase in artery wall mass which
encroached on the lumen, significantly reducing lumen
Fig 2. Photomicrographs demonstrating mouse carotid artery histology (Verhoeff van Gieson stain) 28 days following
unilateral ligation. A representative nonligated artery (A), and a representative ligated artery (B) from a control animal.
Original magnification, both panels, 400.
Table I. Effects of ligation and treatment on artery wall mass and remodeling
Area (m2)  103
(mean  SEM)
Sham
(n  8)
Nonligated Ligated
P
Control
(n  17)
Fasudil
(n  17)
Control
(n  13)
Fasudil
(n  13)
Adventitia 14.8  0.8 14.0  1.0 13.9  0.5 32.0  5.3* 20.3  3.1 .07
Media 16.9  0.6 18.6  0.8 19.5  0.7 30.6  2.4* 24.1  1.6* .03
Neointima 0.0  0.0 0.0  0.0 0.0  0.0 24.4  7.0* 8.5  2.4* .04
Total wall mass
(adventitia  intima  media)
29.7  2.3 30.7  2.4 33.4  1.2 87.1  12.8* 52.9  6.2* .02
Artery Size (EEL area) 80.9  4.3 111.8  5.9* 116.5  4.4* 93.0  11.8 60.1  9.9 .04
Lumen area 62.9  4.2 91.9  5.4* 95.2  4.0* 36.5  8.2* 26.7  7.7* .39
P values are given for comparisons of ligated arteries in fasudil vs. control groups.
*Indicates a significant difference (P  .05) versus sham.
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area.14,15 Although the mechanisms of lesion formation in
this model differ from the traditional models of arterial
injury (eg, angioplasty), the resulting histological changes
are surprisingly similar with marked intimal thickening and
adventitial fibrosis.11,12 Rho-kinase inhibition by the spe-
cific competitive inhibitor fasudil significantly reduced the
increase in wall mass following ligation. However, treat-
ment also blocked outward remodeling in ligated arteries
so that lumen caliber was not improved.
Smooth muscle cell proliferation, migration, and ma-
trix production play an important role in pathologic lumen
narrowing from atherosclerosis and following arterial re-
construction.11-13 Rho-kinase, a key mediator of the Rho
signaling pathway, modulates SMC myosin light chain
kinase and myosin phosphatase, thereby promoting actin-
myosin coupling, resulting in SMC shape changes required
for contraction and migration.1,2,8,9,17,18 Similarly, cell
shape changes likely play an important role in collagen
matrix remodeling. Consistent with this hypothesis, block-
ing Rho-kinase inhibited collagen gel contraction by SMCs
in vitro. Thus, failure of fasudil to promote outward artery
wall remodeling following the 28-day treatment period was
unexpected. Our data are also in contrast to a previous
study of Rho-kinase inhibition in a pig model of interleukin
1 (IL-1)–induced atherosclerosis in which outward remod-
eling was enhanced in diseased coronary arteries.19
In the present study, ligated arteries in the treated mice
were statistically smaller at 28 days than in the controls.
However, ligated arteries in treated mice were not statisti-
cally smaller than sham ligated arteries. This finding sug-
gests that outward remodeling seen in control arteries,
presumably in response to intimal and medial thickening,
was blocked. This suggestion is supported by recent reports
from Godin et al15 and Tuttle et al21 that showed a strong
association between neointimal lesion size after carotid
ligation and outward remodeling. These investigators con-
cluded that remodeling was due in part to inflammation, as
outward remodeling of the vessel wall was associated with
lesion size, macrophage content, and matrix metallopro-
teinase production.15,20 Further support for this concept
comes from Miyata et al7 who demonstrated that inhibiting
Rho-kinase reduced macrophage recruitment and coronary
lesion formation in response to monocyte chemoattractant
protein-1. Whether fasudil actually promoted wall constric-
tion in the present study is not clear, as the reduction in wall
size relative to shams was modest.
Surprisingly, although fasudil blocked outward remod-
eling in response to neointimal hyperplasia, it had no effect
on outward remodeling from increased blood flow. Nonli-
gated arteries in both the treatment and control groups
increased in size in response to contralateral ligation when
compared with shams. This finding is easily explained by
hemodynamic effects, as flow is increased contralateral to
the ligated artery to maintain cerebral blood flow. Al-
though both remodeling mechanisms (injury and flow)
presumably involve related cellular events, these data sug-
gest significant differences in their molecular regulation.
Flow-induced remodeling is thought to be driven largely
by endothelial cell responses to increased shear stress such
as nitric oxide production.21 In the context of intimal
hyperplasia, the endothelium is often absent or dysfunc-
tional because of inflammatory and wound healing
events.11 These present data support a role for Rho-kinase
in remodeling following injury.
Reductions in intimal and medial thickening and a
trend toward significance in reducing adventitial thickening
Fig 3. Bar charts show carotid morphometry data for sham-
operated animals (N 8) and for ligated arteries of control animals
(N  13 animals). Mean  SEM, (*) indicates a significant
difference (P  .05) versus control.
Fig 4. Bar charts show carotid morphometry data of ligated
arteries of control versus treated animals (N 13). Mean SEM,
(*) indicates a significant difference (P  .05) versus control; (**)
indicates P  .07 versus control.
Table II. Cell density (nuclei /mm2  103) after carotid
ligation
Control Treated P
Adventitia 12.6  0.9 10.5  1.0 .17
Media 6.1  0.6 5.5  0.3 .38
Neointima 21.7  3.1 19.8  2.7 .67
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by fasudil in the mouse model are consistent with the effects
of Rho-kinase inhibition in the rat carotid injury model.5,6
In the latter, neointimal thickening was reduced because of
cell loss as a result of enhanced apoptosis.5,6 Treatment did
not alter cell density in the present study, suggesting that
reduced arterial wall mass resulted from either decreased
SMC proliferation or increased apoptosis but not altered
matrix production. However, as we studied only one rela-
tively late time point (28 days), our experimental design did
not allow us to directly measure effects of treatment on
early replication or cell death, but both effects have been
reported in the literature.1,8,17
In summary, Rho-kinase inhibition had favorable ef-
fects on wall mass after ligation; inhibiting neointimal,
medial, and adventitial thickening. Treatment also blocked
outward artery wall remodeling and thereby resulted in
similar lumen caliber relative to controls. In contrast, out-
ward remodeling in response to increased blood flow was
unaltered by inhibition of Rho-kinase, suggesting distinct
molecular regulation of remodeling in response to injury
and flow. Rho-kinase may be an important target to limit
intimal hyperplasia and prevent restenosis when remodel-
ing is enhanced by other means (eg, stents).
We thank Deanna Brown for excellent technical assis-
tance in tissue processing and histology.
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